Agreement grants Quadri Pharmaceuticals Store exclusive promotional, commercialization, and distribution rights in Bahrain, Kuwait, Qatar, Saudi Arabia, the United Arab Emirates, and Oman for human indications of crofelemer approved in the U.S., including future target indications
https://finance.yahoo.com/news/jaguar-health-enters-exclusive-crofelemer-103000712.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.